Patients with COVID-19 admitted to intensive care unit (ICU) have an increased risk of bloodstream infections (BSI), compared to patients without COVID-19. To date, no literature review and meta-analysis of the incidence rate of BSI in these patients is available. A literature review was performed based on a systematic search from January 2020 to December 2023. Eligible studies had to address the incidence rate of BSI in adult patients with COVID-19 admitted to ICU within Europe. Data on incidence and mortality rates was collected. A meta-analysis was conducted to estimate the pooled incidence rate. Twelve studies met eligibility criteria. The incidence rate of BSI in patients with COVID-19 admitted to ICU varied between 6.4 and 92/1000 patient-days with a mortality rate between 25% and 54%. The pooled incidence rate was 29.5/1000 patient-days (95% CI 12.1 - 71.6) with substantial heterogeneity observed. Compared to non-COVID-19 patients admitted to ICU during the pandemic, the incidence rate of BSI was higher. According to this literature review and meta-analysis, the incidence rate of BSI in patients with COVID-19 admitted to ICU is two-fold higher. Clinical teams taking care of these patients should adapt BSI prevention protocols and antimicrobial treatments.
References
[1]
European Centre for Disease Prevention and Control (ECDC) (2024) Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals. https://www.ecdc.europa.eu/sites/default/files/documents/antimicrobial-use-healthcare-associated-infections-point-prevalence-survey-version6-1.pdf
[2]
Ntziora, F. and Giannitsioti, E. (2024) Bloodstream Infections in the Era of the COVID-19 Pandemic: Changing Epidemiology of Antimicrobial Resistance in the Intensive Care Unit. Journal of Intensive Medicine, 4, 269-280. https://doi.org/10.1016/j.jointm.2023.12.004
[3]
Contou, D., Claudinon, A., Pajot, O., Mica？lo, M., Longuet Flandre, P., Dubert, M., et al. (2020) Bacterial and Viral Co-Infections in Patients with Severe SARS-CoV-2 Pneumonia Admitted to a French ICU. Annals of Intensive Care, 10, 119. https://doi.org/10.1186/s13613-020-00736-x
[4]
Bonazzetti, C., Morena, V., Giacomelli, A., Oreni, L., Casalini, G., Galimberti, L.R., etal. (2020) Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study. Critical Care Medicine, 49, e31-e40. https://doi.org/10.1097/ccm.0000000000004748
[5]
Ippolito, M., Simone, B., Filisina, C., Catalanotto, F.R., Catalisano, G., Marino, C., etal. (2021) Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Microorganisms, 9, Article 2016. https://doi.org/10.3390/microorganisms9102016
[6]
Pozza, G., Casalini, G., Ciubotariu, C.L., Giacomelli, A., Galimberti, M., Zacheo, M., et al. (2023) Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves. Antibiotics, 12, Article 1448. https://doi.org/10.3390/antibiotics12091448
[7]
Verberk, J.D.M., van der Kooi, T.I.I., Kampstra, N.A., Reimes, N., van Rooden, S.M., Hopmans, T.E.M., et al. (2023) Healthcare-Associated Infections in Dutch Hospitals during the COVID-19 Pandemic. Antimicrobial Resistance & Infection Control, 12, Article No. 2. https://doi.org/10.1186/s13756-022-01201-z
[8]
Giacobbe, D.R., Battaglini, D., Ball, L., Brunetti, I., Bruzzone, B., Codda, G., et al. (2020) Bloodstream Infections in Critically Ill Patients with COVID-19. European Journal of Clinical Investigation, 50, e13319. https://doi.org/10.1111/eci.13319
[9]
Ramos, R., de la Villa, S., García-Ramos, S., Padilla, B., García-Olivares, P., Pi？ero, P., et al. (2023) COVID-19 Associated Infections in the ICU Setting: A Retrospective Analysis in a Tertiary-Care Hospital. Enfermedades Infecciosas y Microbiología Clínica, 41, 278-283. https://doi.org/10.1016/j.eimc.2021.10.014
[10]
Hlinkova, S., Moraucikova, E., Lesnakova, A., Strzelecka, A. and Littva, V. (2023) Central Line Associated Bloodstream Infections in Critical Ill Patients during and before the COVID-19 Pandemic. Healthcare, 11, Article 2415. https://doi.org/10.3390/healthcare11172415
[11]
Szabó, B.G., Czél, E., Nagy, I., Korózs, D., Petrik, B., Marosi, B., et al. (2023) Clinical and Microbiological Outcomes and Follow-Up of Secondary Bacterial and Fungal Infections among Critically Ill COVID-19 Adult Patients Treated with and without Immunomodulation: A Prospective Cohort Study. Antibiotics, 12, Article 1196. https://doi.org/10.3390/antibiotics12071196
[12]
Lepape, A., Machut, A., Bretonnière, C., Friggeri, A., Vacheron, C. and Savey, A. (2023) Effect of SARS-CoV-2 Infection and Pandemic Period on Healthcare-Associated Infections Acquired in Intensive Care Units. Clinical Microbiology and Infection, 29, 530-536. https://doi.org/10.1016/j.cmi.2022.10.023
[13]
Bonazzetti, C., Rinaldi, M., Giacomelli, A., Colombo, R., Ottolina, D., Rimoldi, S.G., et al. (2023) Risk Factors Associated with Bacteremia in COVID-19 Patients Admitted to Intensive Care Unit: A Retrospective Multicenter Cohort Study. Infection, 51, 129-136. https://doi.org/10.1007/s15010-022-01853-4
[14]
Bloch, N., Rüfenacht, S., Ludwinek, M., Frick, W., Kleger, G., Schneider, F., et al. (2023) Healthcare？Associated Infections in Intensive Care Unit Patients with and without COVID-19: A Single Center Prospective Surveillance Study. Antimicrobial Resistance & Infection Control, 12, Article No. 147. https://doi.org/10.1186/s13756-023-01353-6
[15]
Torrecillas, M., Gumucio, V.D., Padullés, A., Tubau, F., Marco, D., Shaw, E., et al. (2022) Antimicrobial Use and Aetiology of Bloodstream Infections in Critically Ill Patients during Early Stages of SARS-CoV-2 Pandemic. Infection Prevention in Practice, 4, Article 100241. https://doi.org/10.1016/j.infpip.2022.100241
[16]
Massart, N., Maxime, V., Fillatre, P., Razazi, K., Ferré, A., Moine, P., et al. (2021) Characteristics and Prognosis of Bloodstream Infection in Patients with COVID-19 Admitted in the ICU: An Ancillary Study of the COVID-ICU Study. Annals of Intensive Care, 11, Article No. 183. https://doi.org/10.1186/s13613-021-00971-w
[17]
Cataldo, M.A., Tetaj, N., Selleri, M., Marchioni, L., Capone, A., Caraffa, E., et al. (2020) Incidence of Bacterial and Fungal Bloodstream Infections in COVID-19 Patients in Intensive Care: An Alarming “Collateral Effect”. Journal of Global Antimicrobial Resistance, 23, 290-291. https://doi.org/10.1016/j.jgar.2020.10.004
[18]
European Centre for Disease Prevention and Control (ECDC) (2023) Annual Epidemiological Report for 2019—Healthcare-Associated Infections Acquired in Intensive Care Units. ECDC. https://ecdc.europa.eu/sites/default/files/documents/healthcare-associated-infections-intensive-care-units-annual-epidemiological-report-2019.pdf
[19]
European Centre for Disease Prevention and Control (ECDC) (2024) Annual Epidemiological Report for 2016—Healthcare-Associated Infections Acquired in Intensive Care Units. ECDC. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2016-HAI_0.pdf
[20]
European Centre for Disease Prevention and Control (ECDC) (2024) Annual Epidemiological Report for 2017—Healthcare-Associated Infections Acquired in Intensive Care Units. ECDC. https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2017-HAI.pdf
[21]
European Centre for Disease Prevention and Control (ECDC) (2024) Annual Epidemiological Report for 2018—Healthcare-Associated Infections Acquired in Intensive Care Units. ECDC. https://ecdc.europa.eu/sites/default/files/documents/healthcare-associated-infections-intensive-care-units-annual-epidemiological-report-2018.pdf
[22]
Kallel, H., Houcke, S., Resiere, D., Roy, M., Mayence, C., Mathien, C., et al. (2020) Epidemiology and Prognosis of Intensive Care Unit-Acquired Bloodstream Infection. The American Journal of Tropical Medicine and Hygiene, 103, 508-514. https://doi.org/10.4269/ajtmh.19-0877
[23]
Giamarellos-Bourboulis, E.J., Netea, M.G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., et al. (2020) Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host & Microbe, 27, 992-1000.e3. https://doi.org/10.1016/j.chom.2020.04.009
[24]
Cardinale, V., Capurso, G., Ianiro, G., Gasbarrini, A., Arcidiacono, P.G. and Alvaro, D. (2020) Intestinal Permeability Changes with Bacterial Translocation as Key Events Modulating Systemic Host Immune Response to SARS-CoV-2: A Working Hypothesis. Digestive and Liver Disease, 52, 1383-1389. https://doi.org/10.1016/j.dld.2020.09.009
[25]
Wang, J. and Jiang, T. (2025) Risk Factors for Bloodstream Infection in COVID-19 Patients in Intensive Care Units: A Systematic Review and Meta-Analysis. BMC Infectious Diseases, 25, Article No. 13. https://doi.org/10.1186/s12879-024-10420-1
[26]
Tabah, A., Buetti, N., Staiquly, Q., Ruckly, S., Akova, M., Aslan, A.T., et al. (2023) Epidemiology and Outcomes of Hospital-Acquired Bloodstream Infections in Intensive Care Unit Patients: The EUROBACT-2 International Cohort Study. Intensive Care Medicine, 49, 178-190. https://doi.org/10.1007/s00134-022-06944-2
[27]
Pérez-Crespo, P.M.M., Lanz-García, J.F., Bravo-Ferrer, J., Cantón-Bulnes, M.L., Sousa Domínguez, A., Goikoetxea Aguirre, J., et al. (2021) Revisiting the Epidemiology of Bloodstream Infections and Healthcare-Associated Episodes: Results from a Multicentre Prospective Cohort in Spain (PRO-BAC Study). International Journal of Antimicrobial Agents, 58, Article 106352. https://doi.org/10.1016/j.ijantimicag.2021.106352
[28]
Buetti, N., Tabah, A., Loiodice, A., Ruckly, S., Aslan, A.T., Montrucchio, G., et al. (2022) Different Epidemiology of Bloodstream Infections in COVID-19 Compared to Non-COVID-19 Critically Ill Patients: A Descriptive Analysis of the Eurobact II Study. Critical Care, 26, Article No. 319. https://doi.org/10.1186/s13054-022-04166-y
[29]
Toc, D.A., Mihaila, R.M., Botan, A., Bobohalma, C.N., Risteiu, G.A., Simut-Cacuci, B.N., et al. (2022) Enterococcus and COVID-19: The Emergence of a Perfect Storm? International Journal of Translational Medicine, 2, 220-229. https://doi.org/10.3390/ijtm2020020
[30]
Rangel, K. and De-Simone, S.G. (2022) Acinetobacter Baumannii during COVID-19: What Is the Real Pandemic? Pathogens, 12, Article 41. https://doi.org/10.3390/pathogens12010041
[31]
Piantoni, A., Houard, M., Piga, G., Zebian, G., Ruffier des Aimes, S., Holik, B., et al. (2023) Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria. Antibiotics, 12, Article 1105. https://doi.org/10.3390/antibiotics12071105
